about
Genomic confirmation of hybridisation and recent inbreeding in a vector-isolated Leishmania populationRapid tests for the diagnosis of visceral leishmaniasis in patients with suspected diseasePreventive measures for leishmaniasisRapid diagnostic tests for visceral leishmaniasisInterventions for Old World cutaneous leishmaniasisInterventions for American cutaneous and mucocutaneous leishmaniasisInterventions for solitary or limited cutaneous leishmaniasisInterventions for mucocutaneous leishmaniasisMucosal leishmaniasis: an underestimated presentation of a neglected diseaseSingle dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c miceFailure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemicSuccessful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulatorRodent-borne diseases and their risks for public healthTherapeutic enhancement of protective immunity during experimental leishmaniasisMultiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencingEvaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasisGenetics of host response to Leishmania tropica in mice - different control of skin pathology, chemokine reaction, and invasion into spleen and liverDevelopment of novel prime-boost strategies based on a tri-gene fusion recombinant L. tarentolae vaccine against experimental murine visceral leishmaniasisCharacterization of Phlebotomus papatasi peritrophins, and the role of PpPer1 in Leishmania major survival in its natural vectorLmaPA2G4, a homolog of human Ebp1, is an essential gene and inhibits cell proliferation in L. majorFitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania majorDifferential Subcellular Localization of Leishmania Alba-Domain Proteins throughout the Parasite DevelopmentAn Arginine Deprivation Response Pathway Is Induced in Leishmania during Macrophage InvasionClinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine AntimoniateLipophosphoglycans from Leishmania amazonensis Strains Display Immunomodulatory Properties via TLR4 and Do Not Affect Sand Fly InfectionIn vitro anti-Leishmania activity of tetracyclic iridoids from Morinda lucida, benthDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).QBC for the diagnosis of human and canine american visceral leishmaniasis: preliminary data.Human cellular immune response to the saliva of Phlebotomus papatasi is mediated by IL-10-producing CD8+ T cells and Th1-polarized CD4+ lymphocytesEvaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral LeishmaniasisMapping of a Leishmania major gene/locus that confers pentamidine resistance by deletion and insertion of transposable element.Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil.Differential protein expression analysis of Leishmania major reveals novel roles for methionine adenosyltransferase and S-adenosylmethionine in methotrexate resistance.The attachment and entry of Leishmania (Leishmania) major into macrophages: observation by scanning electron microscope.A 3D-QSAR CoMSIA study on 3-azolylmethylindoles as anti-leishmanial agents.Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting.Transgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes.A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania.Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study.Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection.
P2860
Q21144880-300CF941-2C0A-48AC-962C-264713C45038Q24193697-ED961797-59EE-4961-8BC9-93970283F85EQ24234937-0C9241AB-93A1-46FB-B9A2-11CEAB7B0E77Q24236732-90AC5F65-A52A-4BA9-B4A9-5E6A6AE04D01Q24241245-999EE35F-0224-4E77-8DB8-11749E8896A2Q24241646-9E75F982-FF1D-4627-A038-6BF41A0F4F78Q24245219-268674AD-6CA2-4F42-8F79-6ABD71AFA0EDQ24246967-EBB35C9E-C0CD-4836-B7D3-E5F334883556Q26998036-604D2506-7912-4727-8286-0C3EBA6A4BF2Q27305906-2C308C81-3414-46DD-B802-96C3D92F6945Q28142100-7AB15612-C77E-4DE1-A012-979B9F9FD8BDQ28203663-5DF1EB2D-1FAE-49E5-956A-227025400055Q28249580-F9F8BC2B-0719-4ADC-9B4E-9CA4530EA929Q28476803-282FF5E2-5F5E-4408-AE40-888B8AE32506Q28480626-578B0824-4045-4409-A604-A0CFB1F2CCE4Q28483086-AA784184-C960-4818-828B-4DA616E20473Q28484114-0150BA1F-8448-46F4-BCDA-137B8FE7E287Q28486287-B382C42B-DE33-49E2-9CFF-00788A7CD670Q28487978-973A4F5A-49FA-416E-B7FE-F9A95ADAA50AQ28538628-6B9E785F-E368-4FCD-889C-D0E239EE5672Q28546940-6C3BF51A-2B77-4780-B232-69DEB6241ADEQ28547740-085E19D8-AC41-4B95-9E58-83ADE29DAA67Q28551602-57625AD4-A524-4540-A702-1C9D0F92D23FQ28552530-F58288D8-A8C1-49DE-B9A3-F3F1ED91F85BQ28553439-F215CE8E-C463-4A00-BD1D-044474A287EBQ28831274-7F1629BA-E649-4F7D-BBD4-A769960AC31FQ30275257-D725A670-0B93-4832-AC8D-8F611BF0B594Q30670984-C42E8064-5505-4F71-84F0-2561AD9C6788Q31032971-EB66F5D4-C3E6-4DC2-85E5-4DA4E9C09BFCQ31060208-5E9AD714-2C61-4513-81E7-98328732ADF0Q31061018-5ED932AD-E424-4627-BC6A-F423DA64EB91Q31796135-B15CF9A8-EE57-4EC0-83BF-20D9CC3DBE33Q33203657-877477B7-FC17-48E0-A4AE-9F0888479C69Q33228820-53439C95-D8EE-436E-A954-D867375EA37AQ33248615-8FB13404-EB66-4A7E-83A7-19278048A6B0Q33270962-020ACB00-1FE6-4591-A905-6D26EFB77FE8Q33334019-B3967510-63BD-444C-B509-6F9B9B79DC9CQ33342808-F7AC5CAC-3D4D-4B27-93F8-A382A22881E5Q33391670-578E91EB-1689-47F4-90D1-EA142DA1A2C4Q33402474-D6344FCC-87EB-4B30-BAFE-A7F877457A0D
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im Oktober 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
наукова стаття, опублікована в жовтні 1999
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Leishmaniasis
@en
type
label
Leishmaniasis
@en
prefLabel
Leishmaniasis
@en
P1433
P1476
Leishmaniasis
@en
P2093
Barbara L Herwaldt
P304
P356
10.1016/S0140-6736(98)10178-2
P407
P577
1999-10-01T00:00:00Z